Key Takeaways
- • William Blair has acquired Armentum Partners, a boutique debt and alternative capital solutions advisory firm serving venture-backed businesses, public companies, and academic institutions, according to a Business Wire release dated October 19, 2026.
- • The deal is William Blair's second investment banking acquisition of the year and adds enterprise value lending, asset-based lending, and royalty monetization capabilities to its capital markets and debt advisory platform.
- • Armentum has raised over $22 billion across more than 390 transactions since inception, and all of its professionals have joined William Blair.
- • William Blair will open an office in Menlo Park, establishing a Silicon Valley presence, while Armentum continues operating under its existing name for a period after closing.
- • The transaction follows rapid growth in private credit and direct lending as venture-backed and public companies seek non-dilutive capital.
Summary
Armentum Partners advises high-growth companies on bespoke capital solutions, drawing on venture capital and public company relationships and access to growth-focused and enterprise-value lenders. The firm also advises academic institutions and life sciences companies on royalty monetization. According to the release, Armentum's senior bankers have more than 200 years of combined experience, and the firm has raised over $22 billion since inception across 390+ transactions. Its professionals are based in Boston, Chicago, Menlo Park, New York, Philadelphia, and San Francisco, serving clients in the U.S. and Europe. As part of the transaction, William Blair will open a Menlo Park office, and all Armentum professionals have joined the firm.
Matt Zimmer, global head of investment banking at William Blair, said the acquisition extends the firm's offering across the venture capital, public company, and collegiate communities. Steve Maletzky, head of capital markets, described enterprise value lending as a specialized discipline that finances companies against the value of their assets, often before traditional cash flows exist. Armentum's Hutch Corbett said the combined firm will offer expanded services, including public and private equity capital raising, M&A advisory, secondary advisory, primary fund raising, and equity research.
The acquisition arrives amid rapid expansion in private credit and direct lending, as companies in healthcare innovation, artificial intelligence, software, fintech, and industrial technology increasingly seek flexible, non-dilutive capital. Demand has been particularly strong among later-stage technology and biopharmaceutical firms financing clinical trials and commercialization. Armentum will continue operating under its current name for a period after closing. Clearsight Advisors, Inc. served as financial advisor to Armentum. Financial terms of the transaction were not disclosed in the release.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.